Release Date: 15/12/11 16:23 Summary: December 2011 Quarterly Distribution Price Sensitive: Yes Download Document 29.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%